USC’s Vsevolod “Seva” Katritch discusses how structure-based virtual screening and AI could disrupt the time-consuming, expensive process of drug discovery.
Growing evidence suggests that U.S. consumers overpay for generics by as much as 20% while pharmacy benefit managers pad profits, a USC Schaeffer Center white paper finds.
Among older Americans surveyed in the weeks after FDA approval of aducanumab, few could correctly answer true or false questions about the first new Alzheimer’s drug in decades.
Opioid-related deaths among Blacks, Asians and Latinos dropped during the same period, according to a study from USC and the L.A. County Medical Examiner-Coroner’s Office.
One in 10 adults were at risk of overdose, with older Americans relying on high doses of opioids more than younger adults, researchers found in a national sample of prescription claims.
A new approach could help doctors diagnose and treat patients within the critical first hour after an accident.
USC experts search for answers to deadly superbugs.
According to a new USC study, dihydromyricetin — an over-the-counter herbal hangover cure — may also help people cope with alcoholism and liver damage.
Having a wider array of people participating in medical research is crucial to advancing care for all patients.
A new study from the USC Schaeffer Center found that fewer than 5% of state drug pricing laws passed between 2015 and 2018 will provide additional public transparency.
